Health care industry players that focus on developing essential vaccines and therapies are rightfully gaining widespread visibility amid the global pandemic. However, we’re closely watching a set of more niche, under-the-radar health care innovations that hold potential for addressing highly specific and urgent needs in the battle against COVID-19. In this blog post, we’ll tell the stories of four themes that can improve the health of our society and economy while offering potential opportunities for investors.

We believe investors should be paying attention to the Holding Foreign Companies Accountable Act (Kennedy-Van Hollen bill). A core component of the legislation requires companies to certify that they are not under the control of a foreign government. If a company can’t show this—or the Public Company Accounting Oversight Board (PCAOB) isn’t able to audit the company for three consecutive years to determine that it’s not under the control of a foreign government—then the company’s securities would be banned from U.S. stock exchanges.